Pazopanib treatment outcome in advanced soft tissue sarcoma: Real-world data

被引：0
|
作者：
Alshamsan, B. [1 ]
Alshibany, A. [2 ]
Badran, A. [3 ]
Maraiki, F. [2 ]
Elshenawy, M. A. [4 ]
Elhassan, T. [2 ]
Atallah, J. P. [2 ]
机构：
[1] Qassim Univ, Dept Med, Coll Med, Qasim, Saudi Arabia
[2] King Faisal Specialist Hosp & Res Ctr, Ctr Canc, Med Oncol, Riyadh, Saudi Arabia
[3] Ain Shams Univ Hosp, Dept Clin Oncol, Ain Shams, Egypt
[4] Menoufia Univ, Fac Med, Clin Oncol, Shibin Al Kawm, Menoufia Govern, Egypt
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.08.1883
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1657P
引用
下载
收藏
页码：S987 / S987
页数：1
相关论文
共 50 条
  • [21] Pazopanib and the treatment palette for soft-tissue sarcoma
    Bramwell, Vivien H. C.
    LANCET, 2012, 379 (9829): : 1854 - 1856
  • [22] A molecular signature predictive of clinical outcome following pazopanib therapy in advanced soft tissue sarcoma
    Huang, P.
    Lee, A.
    McCarthy, F.
    Thway, K.
    Morden, J.
    Messiou, C.
    Daley, F.
    Buus, R.
    Fisher, C.
    Cheang, M.
    Judson, I.
    Jones, R.
    ANNALS OF ONCOLOGY, 2017, 28 : 149 - 149
  • [23] Incidence of Pneumothorax in Advanced and/or Metastatic Soft Tissue Sarcoma Patients during Pazopanib Treatment
    Nakano, K.
    Inagaki, L.
    Tomomatsu, J.
    Motoi, N.
    Gokita, T.
    Ae, K.
    Tanizawa, T.
    Shimoji, T.
    Matsumoto, S.
    Takahashi, S.
    CLINICAL ONCOLOGY, 2014, 26 (06) : 357 - 357
  • [24] Genomic analysis of predictive biomarker for pazopanib treatment in patients with advanced soft tissue sarcoma
    Sekimizu, Masaya
    Asano, Naofumi
    Mitani, Sachiyo
    Yamazaki, Fumito
    Kubo, Takashi
    Yoshida, Akihiko
    Kobayashi, Eisuke
    Iwata, Shintaro
    Kamoda, Hiroto
    Yonemoto, Tsukasa
    Inagaki, Katsunori
    Kawai, Akira
    Ichikawa, Hitoshi
    CANCER SCIENCE, 2018, 109 : 294 - 294
  • [25] Real-world data of a cohort of patients with soft tissue sarcoma in a single institution of Colombia.
    Eduardo Pino, Luis
    Camilo Triana, Ivan
    Ospina Serrano, Aylen Vanessa
    Segovia, Javier
    Carolina Hennessey, Diana
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [26] Real-world efficacy, safety data and predictive clinical parameters for treatment outcomes in advanced soft tissue sarcoma treated with combined immunotherapy and antiangiogenic therapy
    Li, Shaoli
    Sun, Qunan
    Bai, Rui
    Wang, Youping
    Wang, Hui
    Chen, Haifeng
    Dong, Ying
    BMC CANCER, 2024, 24 (01)
  • [27] Pazopanib for soft-tissue sarcoma: a PALETTE of data emerges
    Isabelle Ray-Coquard
    David Thomas
    Nature Reviews Clinical Oncology, 2012, 9 : 431 - 432
  • [28] Pazopanib as new therapeutic option in therapy of advanced soft tissue sarcoma
    Jagiello-Wieczorek, Ewelina
    Switaj, Tomasz
    Jagielska, Beata
    Falkowski, Slawomir
    Rutkowski, Piotr
    ONCOLOGY IN CLINICAL PRACTICE, 2014, 10 (01): : 24 - 31
  • [29] The real-life outcome of pazopanib in patients with advanced soft tissue sarcoma: A retrospective cross-sectional study of a Turkish cohort
    Karaagac, Mustafa
    Sezgin, Yasin
    Eryilmaz, Melek Karakurt
    Araz, Murat
    Kaplan, Muhammet Ali
    Artac, Mehmet
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2020, 26 (07) : 1657 - 1666
  • [30] Risk factors of pneumothorax in advanced and/or metastatic soft tissue sarcoma patients during pazopanib treatment
    Nakano, Kenji
    Motoi, Noriko
    Tomomatsu, Junichi
    Gokita, Tabu
    Ae, Keisuke
    Tanizawa, Taisuke
    Shimoji, Takashi
    Matsumoto, Seiichi
    Takahashi, Shunji
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345